International Gemmological Institute India Ltd vs Medi Assist Healthcare Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of International Gemmological Institute (India) Ltd is ₹ 338.65 as of 20 Mar 15:30 . The P/E Ratio of International Gemmological Institute (India) Ltd changed from 56 on December 2024 to 56 on December 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Medi Assist Healthcare Services Ltd changed from 53 on March 2024 to 0 on December 2024 . This represents a CAGR of -100.00% over 5 years The Market Cap of International Gemmological Institute (India) Ltd changed from ₹ 23917 crore on December 2024 to ₹ 23917 crore on December 2024 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Medi Assist Healthcare Services Ltd changed from ₹ 3548 crore on March 2024 to ₹ 0 crore on December 2024 . This represents a CAGR of -100.00% over 5 years The revenue of International Gemmological Institute (India) Ltd for the Mar '25 is ₹ 331.05 crore as compare to the Dec '25 revenue of ₹ 316.21 crore. This represent the growth of 4.69% The revenue of Medi Assist Healthcare Services Ltd for the Mar '25 is ₹ 196.64 crore as compare to the Dec '25 revenue of ₹ 247.24 crore. This represent the decline of -20.47% The ebitda of International Gemmological Institute (India) Ltd for the Mar '25 is ₹ 202.73 crore as compare to the Dec '25 ebitda of ₹ 188.65 crore. This represent the growth of 7.46% The ebitda of Medi Assist Healthcare Services Ltd for the Mar '25 is ₹ 48.47 crore as compare to the Dec '25 ebitda of ₹ 37.99 crore. This represent the growth of 27.59% The net profit of International Gemmological Institute (India) Ltd changed from ₹ 126.08 crore to ₹ 134.55 crore over 7 quarters. This represents a CAGR of 3.79% The net profit of Medi Assist Healthcare Services Ltd changed from ₹ 18.95 crore to ₹ 21.59 crore over 7 quarters. This represents a CAGR of 7.74% The Dividend Payout of International Gemmological Institute (India) Ltd changed from 24.01 % on December 2024 to 24.01 % on December 2024 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Medi Assist Healthcare Services Ltd changed from 70.33 % on March 2022 to 0 % on December 2024 . This represents a CAGR of -100.00% over 8 years .

About International Gemmological Institute (India) Ltd

International Gemological Institute India Limited was incorporated as International Gemmological Institute (India) Private Limited' at Mumbai, Maharashtra as a Private Limited Company, pursuant to a Certificate of Incorporation dated February 23, 1999, issued by the Registrar of Companies, Maharashtra at Mumbai, which subsequently got converted to Public Limited Company and the name of Company has changed to International Gemmological Institute (India) Limited' vide fresh Certificate of Incorporation dated July 10, 2024 issued by the RoC. IGI India is part of the International Gemmological Institute (IGI) Group.
The primary business is the provision of services related to the certification and accreditation of natural diamonds, laboratory grown diamonds, studded jewelry and colored stones as well as educational programs.

About Medi Assist Healthcare Services Ltd

Medi Assist Healthcare Services Limited was formerly incorporated on June 7, 2000 as a private Company as 'Net Logistics Private Limited'.
Subsequently, the name of the Company was changed to 'Medi Assist Healthcare Services Private Limited' on November 21, 2012 and further upon the conversion to a Public Limited Company, the name was changed to 'Medi Assist Healthcare Services Limited' w.e.f.
March 20, 2018. Medi Assist Healthcare Services Limited operates as a premier health benefits administrator, providing essential connectivity between insurers, healthcare providers, and members across international markets.
The Company delivers a comprehensive portfolio of services, including claims management, fraud prevention, and provider network administration.
The Company's operations have transitioned from a traditional third-party administration to encompass full-spectrum health benefits management.

FAQs for the comparison of International Gemmological Institute (India) Ltd and Medi Assist Healthcare Services Ltd

Which company has a larger market capitalization, International Gemmological Institute (India) Ltd or Medi Assist Healthcare Services Ltd?

Market cap of International Gemmological Institute (India) Ltd is 14,635 Cr while Market cap of Medi Assist Healthcare Services Ltd is 2,419 Cr

What are the key factors driving the stock performance of International Gemmological Institute (India) Ltd and Medi Assist Healthcare Services Ltd?

The stock performance of International Gemmological Institute (India) Ltd and Medi Assist Healthcare Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for International Gemmological Institute (India) Ltd and Medi Assist Healthcare Services Ltd?

As of March 23, 2026, the International Gemmological Institute (India) Ltd stock price is INR ₹338.65. On the other hand, Medi Assist Healthcare Services Ltd stock price is INR ₹324.3.

How do dividend payouts of International Gemmological Institute (India) Ltd and Medi Assist Healthcare Services Ltd compare?

To compare the dividend payouts of International Gemmological Institute (India) Ltd and Medi Assist Healthcare Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.